ARCHIVES

DCT Board Approves Concepts Of Eight New Biological Response Modifiers Program

This article is from The Cancer Letter archive.

Vol. 07 No. 27 | July 3, 1981

Download PDF Visit The Full Archive

Related Articles

Carcinogenesis Testing To Stay In NCI, But Control Will Go To New Group Headed By Rall

September 15, 1978

In Brief: Friedman Leads FDA During Search; Mead Retires From NCI; Freireich Honored

March 14, 1997

RFP, RFA Available

March 26, 1993

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Ganz Awarded Professor Of Survivorship By Komen.

January 28, 2000

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976